Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors

Two new studies demonstrate that so-called 'liquid biopsies' may reveal important genomic information needed to monitor treatment responses, forecast tumor recurrences, and provide a rationale for novel therapeutic strategies in patients with lung cancer and colon cancer.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Longitudinal monitoring of cfDNA in a patient with a solid tumor.

Marina Corral Spence/Nature Publishing Group

References

  1. 1

    Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).

    CAS  Article  Google Scholar 

  2. 2

    Yap, T.A., Gerlinger, M., Futreal, P.A., Pusztai, L. & Swanton, C. Sci. Transl. Med. 4, 127ps110 (2012).

    Article  Google Scholar 

  3. 3

    Thress, K.S. et al. Nat. Med. 21, 560–562 (2015).

    CAS  Article  Google Scholar 

  4. 4

    Siravegna, G. et al. Nat. Med. 21, 795–801 (2015).

    CAS  Article  Google Scholar 

  5. 5

    Yu, H.A., Riely, G.J. & Lovly, C.M. Clin. Cancer Res. 20, 5898–5907 (2014).

    CAS  Article  Google Scholar 

  6. 6

    Sequist, L.V. et al. Sci. Transl. Med. 3, 75ra26 (2011).

    Article  Google Scholar 

  7. 7

    Cross, D.A. et al. Cancer Discov. 4, 1046 (2014).

    CAS  Article  Google Scholar 

  8. 8

    Jänne, P.A. et al. N. Engl. J. Med. 372, 1689–1699 (2015).

    Article  Google Scholar 

  9. 9

    Misale, S., Di Nicolantonio, F., Sartore-Bianchi, A., Siena, S. & Bardelli, A. Cancer Discov. 4, 1269–1280 (2014).

    CAS  Article  Google Scholar 

  10. 10

    Misale, S. et al. Nature 486, 532–536 (2012).

    CAS  Article  Google Scholar 

  11. 11

    Piotrowska, Z. et al. Cancer Discov. 10.1158/2159-8290.CD-15-0399 (2015).

  12. 12

    Krebs, M.G. et al. Nat. Rev. Clin. Oncol. 11, 129–144 (2014).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Christine M Lovly.

Ethics declarations

Competing interests

C.M.L. has served as a consultant for Pfizer, Novartis, and Sequenom and has been an invited speaker for Abbott and Qiagen. C.M.L. has received research support from AstraZeneca and Novartis.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Meador, C., Lovly, C. Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors. Nat Med 21, 663–665 (2015). https://doi.org/10.1038/nm.3899

Download citation

Further reading